Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fleming

Explore full profile

Modern healthcare support with artificial intelligence for both patient and doctor

Vilnius, LithuaniaFounded 2020Health Tech & Medtech
Valuation $5–10M Last recorded · 2021
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Fleming and the history behind them.

About Fleming

Fleming.app is a health-tech startup that aims to simplify and streamline the self-care process for individuals. Recognizing the potential pitfalls of self-diagnosis and misinterpretation of medical data, Fleming.app offers a solution that makes health management safer and more efficient. The company operates in the digital health market, serving a broad range of clients including individuals, medical apps, platforms, services, clinics, and hospitals.

Read full description

The company's business model revolves around its proprietary API, which integrates into other medical apps and platforms. This API provides continuous access to medical data from patients' daily lives, enabling faster and more efficient communication of this data. This real-time access to crucial medical data can greatly assist clinics and hospitals in their operations.

Fleming.app also offers an automated artificial intelligence platform that can identify potential diseases. This platform is backed by a comprehensive and centralized database of all diseases and symptoms. The company's innovative and educational medical telehealth solutions, which include premedical diagnoses based on AI algorithms and integrated health monitoring, are currently in beta version.

Fleming.app's project is funded by the European Regional Development Fund and is in partnership with Vilnius University of Applied Science. The project, which started in September 2020, aims to contribute to the national medicine development, reorganization, and digitization of primary healthcare in Lithuania.

The company generates revenue through its API and its AI-based disease identification platform, both of which are offered to businesses in the healthcare sector.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Vilnius, Lithuania
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • European Regional Development Fund
  • Kilo
  • European Innovation Council
Employees mapped 143 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 28 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇱🇹 Lithuania95.1%
🇪🇸 Spain2.5%
🇵🇾 Paraguay1.2%
🇨🇦 Canada1.2%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Fleming on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fleming on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.